Purchase Order W81K0021P0091
- Not listed
- The Department of the Army Medical Command awarded Biomerieux Inc., a foreign-owned for-profit manufacturer, a 6-month firm-fixed-price purchase order contract valued at $247,451.00 for a microbial analyzer and related testing services. The contract does not have a set-aside designation. Biomerieux Inc. has previously provided clinical diagnostic testing products, equipment, and services to federal agencies such as the Departments of Veterans Affairs, Defense, Agriculture, and Health and Human...
- The Department of the Army Medical Command awarded a $239,903 firm-fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of the BACT/ALERT FA PLUS (100 per) microbiology testing system and associated reagents. This requirement was initially a sources sought notice to determine the availability of qualified sources for an automated blood culture monitoring and sepsis detection system to support...
- The Department of the Army Medical Command awarded a $248,363.85 firm fixed-price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, to provide microbial reagent consumables. This award was made without a set-aside requirement and is set to be completed by September 30, 2020. The original sources sought notification indicates the Army was conducting market research to identify suppliers capable of leasing a microbial identification and susceptibility...
- The Department of the Army Medical Command awarded a firm fixed price definitive contract to Biomerieux Inc., a foreign-owned for-profit manufacturer, to provide a blood culture system and related supplies. The contract has a potential value of $198,337.60 and a completion date of August 14, 2022. The original solicitation was for a blood culture detection system. Biomerieux Inc. is a worldwide leader in in vitro diagnostics and has provided a range of clinical diagnostic testing products,...
- The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Biomerieux Inc. for the supply of 0017 "SUSEPTIBILITY CARDS" with a ceiling value of $867,621.50. The period of performance runs from October 1, 2020 through September 30, 2023. This requirement was not set aside for any small business category. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its specialized microbiological testing solutions to support infectious disease...
- This contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a manufacturer of in vitro diagnostic products, for GN/GP SUSCEPTIBILITY TESTS. The $118,319.58 firm-fixed-price purchase order contract has a completion date of September 30, 2018. Biomerieux Inc. is a foreign-owned, for-profit organization that produces medical diagnostic equipment and supplies. This award is not associated with a set-aside program. Biomerieux Inc. has experience providing a range of...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of a microbiology analyzer and associated maintenance and supplies. The contract has a potential value of $105,805.80 and a completion date of October 31, 2023. No set-aside designation is mentioned. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, offering clinical testing solutions and equipment,...
- The Department of the Army Medical Command awarded a $197,358.40 Firm Fixed Price delivery order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostics products. The contract is for the delivery of Gram Negative Susceptibility Kits to the Madigan Hospital in Washington. This award is not associated with a set-aside program. Biomerieux Inc. has a history of providing a range of clinical diagnostic testing products, equipment, and services to federal...
- This is a purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostics, for laboratory analyzers. The contract has a firm-fixed price of $107,591.73 and a completion date of April 29, 2021. There was no set-aside designation for this award. Biomerieux Inc. is a global leader in in vitro diagnostics, providing solutions for medical and industrial applications, including proprietary microbiology...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of medical diagnostic goods. The $101,585.60 contract is for clinical microbial identification and susceptibility testing services to support the VA's infectious disease testing needs. Biomerieux Inc. provides a range of proprietary microbiology and molecular biology diagnostic platforms, reagents, and...
The U.S. Department of the Army Medical Command awarded a $247,438.60 firm fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer, for the identification and susceptibility testing of microbes at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas. The contract does not have a set-aside designation. The original solicitation, W81K00-21-Q-0068, was issued by the Regional Health Contracting Office-Central, seeking reagents compatible with Biomerieux's existing on-site equipment for microbial identification, antimicrobial susceptibility testing, and blood culture testing. This contract is likely part of Biomerieux's existing indefinite delivery contracts and blanket purchase agreements with federal agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and Department of Agriculture to provide clinical diagnostic testing products, equipment, and services to support infectious disease testing and food safety programs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Susceptibility Reagents for Government Owned Equipment | W81K00-21-Q-0068 | Department of the Army Medical Command | Award Notice 4/4 | 4/1/21, 10:21 AM | |
Pre-Solicitation Notice for Reagents for Government Owned Equipment | W81K00-21-Q-0068 | Department of the Army Medical Command | Pre-Solicitation 1/4 | 3/11/21, 5:42 PM | |
ID and Susceptibility Reagents for Government Owned Equipment | W81K00-21-Q-0068-0001 | Department of the Army Medical Command | Solicitation 3/4 | 3/25/21, 5:13 PM | |
Solicitation Notice for Reagents for Government Owned Equipment | W81K0021Q0068 | Department of the Army Medical Command | Solicitation 2/4 | 3/17/21, 7:14 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/31/21 |